SCHEMBL4968420

SCHEMBL4968420

CS(=O)(=O)c1ncc(-c2nc(N)ncc2F)n1C1CCOCC1

nearest known ligand 0.35

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 13/20 0.35
MTOR P42345 4/20 0.35
AKT1 P31749 2/20 0.35
ATM Q13315 1/20 0.35
ATR Q13535 1/20 0.35
MAPK14 Q16539 2/20 0.35
MAPK8 P45983 1/20 0.35
PIK3R1 P27986 9/20 0.33
PIK3CD O00329 1/20 0.33
PIK3CB P42338 1/20 0.33
PI4KA P42356 1/20 0.32
PIK3CG P48736 1/20 0.32
FEN1 P39748 1/20 0.32
JAK2 O60674 1/20 0.32
JAK1 P23458 1/20 0.32
JAK3 P52333 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL633585 0.84 PIK3CA (0.39) PIK3CAMTORAKT1ATMATR
SCHEMBL4251746 0.79 PIK3CA (0.36) PIK3CAMTORAKT1ATMATR
SCHEMBL1448068 0.73 CYP11B2 (0.34) PIK3CAMTOR
SCHEMBL4245167 0.72 MAPK14 (0.43) PIK3CAMTORMAPK14PIK3R1FEN1
SCHEMBL4246503 0.72 ALDH1A1 (0.38) PIK3CAMTORMAPK14JAK2JAK1
SCHEMBL14092794 0.72 CDK2 (0.39) PIK3CAMTORAKT1MAPK14MAPK8
Hydrochloric Acid SCHEMBL4964435 0.71 JAK2 (0.41) MAPK14MAPK8JAK2JAK1JAK3
SCHEMBL4462397 0.70 CDK1 (0.55) MAPK14MAPK8
SCHEMBL4249428 0.70 CDK2 (0.39) PIK3CAMAPK14PIK3CBJAK2JAK1
SCHEMBL4426967 0.70 CDK2 (0.38) PIK3CAMTORAKT1MAPK14MAPK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1945628-A1 NEW PYRIMIDINE DERIVATIVES AND THEIR USE IN THERAPY AS WELL AS THE USE OF PYRIMIDINE DERIVATIVES IN THE MANUFACTURE OF A MEDICAMENT FOR PREVENTION AND/OR TREATMENT OF ALZHEIMER'S DISEASE AstraZeneca AB (SE) 2008-07-23 EP disclosed
WO-2007040440-A1 NEW PYRIMIDINE DERIVATIVES AND THEIR USE IN THERAPY AS WELL AS THE USE OF PYRIMIDINE DERIVATIVES IN THE MANUFACTURE OF A MEDICAMENT FOR PREVENTION AND/OR TREATMENT OF ALZHEIMER’S DISEASE ASTRAZENECA AB (SE) 2007-04-12 WO disclosed